Skip to main content
Find more clinical trials

MIND Diet to Prevent Cognitive Decline

Start: January 2017
End: June 30, 2021
Enrollment: 600

What Is This Study About?

This study will test the effects of the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet on cognitive decline in seniors without cognitive impairment who are overweight and have suboptimal diets. The MIND diet combines the Mediterranean diet and Dietary Approaches to Stop Hypertension (DASH).

Do I Qualify To Participate in This Study?

Minimum Age: 65 Years

Maximum Age: 84 Years

Must have:

  • Suboptimal diet
  • Body mass index greater than or equal to 25
  • Family history of dementia

Must NOT have:

  • Heavy alcohol use
  • Severe illness
  • Cognitive impairment
  • Psychiatric illness

If I Qualify, Who Do I Contact?

Contact study personnel listed either under the general study contact or the location nearest you.


Who Is the General Study Contact?

For more information on this trial, visit

Need Help?

Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.

Where Is This Study Located?

Who Sponsors This Study?

Lead: Rush University Medical Center

Collaborator Sponsor

  • Harvard School of Public Health
  • Brigham and Women's Hospital
  • National Institute on Aging (NIA)

Source: ID: NCT02817074